The Cdx1 homeobox gene encodes for an intestinespeci®c transcription factor involved in the control of proliferation and dierentiation of epithelial cells. Although it has been indicated that Cdx1 may act as a proto-oncogene in cultured ®broblasts, its direct role in the regulation of intestinal tumorigenesis has not been demonstrated. Here we show that expression of Cdx1 in an intestinal epithelial cell line (IEC-6) induces anchorage-independent growth in soft agar and promotes the formation of adenocarcinoma in vivo. The phenotype of Cdx1-induced tumors was exacerbated when IEC-6/ Cdx1 cells were injected together with matrigel containing mitogens and extracellular matrix components. These changes were correlated with an increase in the GTPbound form of Ras, modulation of Cdc42 and Rho-A activities, and accumulation of phosphatidyl inositol 3 (PI3) kinase products. Moreover, combined inhibition of Ras/Rho and PI3 kinase signaling by syntethic inhibitors blocked colony formation of IEC-6/Cdx1 cells in soft agar. Taken together, these results demonstrate a direct involvement of Cdx1, and its collaboration with Ras, Rho and PI3 kinase pathways, in transformation and tumorigenesis of intestinal epithelial cells. Oncogene (2001) 20, 4180 ± 4187.
Introduction
Homeobox genes encode for nuclear transcription factors involved in establishing patterns of dierentiation during development and in maintaining these patterns in adult tissues (Bell et al., 1999; Duluc et al., 1997) . The central homeobox domain binds directly to speci®c DNA motifs to trigger transcription of numerous target genes, while¯anking regions provide activating or repressing functions (Chariot et al., 1999) . Systematic searches for Hox target genes have shown that a single Hox gene can have a large number of targets, including other Hox genes, transcription factors and membrane proteins (Isaacs et al., 1998; Knittel et al., 1995) . Several reports have also shown that Hox genes are involved in uncontrolled cell proliferation and oncogenesis (Maulbecker and Gruss, 1993; Bijl et al., 1997) .
The caudal-related homeobox genes, Cdx1 and Cdx2, play crucial roles in the regulation of intestinal cell proliferation and dierentiation (Suh and Traber, 1996; Soubeyran et al., 1999) . Both genes are speci®cally expressed in the epithelium of the small intestine and colon. Cdx1 is predominantly localized in undierentiated cells of intestinal crypts, while Cdx2 is expressed at high levels in the dierentiated enterocytes (James et al., 1994) . In addition to the regulation of epithelial cell proliferation and dierentiation, Cdx genes were also implicated in tumorigenesis in the intestinal tract. Others and we have detected a decrease in expression levels of Cdx1 and Cdx2 in colorectal cancers (Ee et al., 1995; Mallo et al., 1997) , and several studies describe the genetic alteration of Cdx2 during colon cancerogenesis (Wicking et al., 1998; da Costa et al., 1999) . On the contrary, overexpression of Cdx1, as well as many other Hox genes, leads to oncogenic transformation of cultured ®broblasts (Maulbecker and Gruss, 1993) . Moreover, ectopic expression of Cdx1 coincides with the development of metaplasia in gastric and esophagus cancers (Silberg et al., 1997) , suggesting that Cdx1 may be involved in cell transformation and tumor progression of the gastrointestinal tract.
In this report we demonstrate that Cdx1 acts as an oncogene in intestinal epithelial cells. Overexpression of Cdx1 in IEC-6 cells leads to cell transformation in tissue culture and promotes tumor growth in vivo. Furthermore, we show that this transforming potential is mediated through the Ras, Rho and PI3 kinase pathways.
Results
To examine whether Cdx1 participates in a regulatory network that ultimately determines the intestinal phenotype, we investigated the eect of Cdx1 expres-sion in IEC-6 cells, a spontaneously immortalized epithelial cell line derived from the rat intestine (Quaroni et al., 1979) . Cdx1 expression in IEC-6 cells (IEC-6/Cdx1 cells) led to increased migration, proliferation and partial cellular dierentiation resembling the proliferating/transit cells of the intestinal crypt (Soubeyran et al., 1999) . In addition, IEC-6/Cdx1 cells were more resistant to apoptosis when compared to mock-transfected IEC-6 cells (Soubeyran et al., 1999) . To assess the transforming capacity of Cdx1, IEC-6/ Cdx1 were tested for their anchorage-independent growth in a colony forming soft agar assay. IEC-6 cells did not form any colonies in soft agars, while IEC-6/Cdx1 cells rapidly grew numerous colonies ( Figure 1a ). Experiments were repeated three times and the density of IEC-6/Cdx-1 colonies grown in agar was correlated with the increasing number of seeded cells (Figure 1b) . For every experiment v-Src or v-Met transformed ®broblasts were used as positive controls (Figure 1 ).
Since these studies demonstrated the potency of IEC-6/Cdx1 cells to grow in a semisolid medium, we further evaluated their ability to form tumors in vivo using immunologically compromised mice. Cells were injected subcutaneously into nude mice and mice were subsequently followed for tumor appearance and growth. Parental IEC-6 cells did not grow any tumors under these conditions (Figure 2a) . On the contrary, injection of IEC-6/Cdx1 cells in nude mice promoted the formation of slowly developing tumors throughout a 12-week period in all injected mice, while v-Src or vMet transformed ®broblasts gave rise to very rapidly growing tumors (Figure 2a,b) . IEC-6/Cdx1 tumor cells were isolated and grown in DMEM in the presence of G418 and shown to be identical to the original IEC-6/ Cdx1 cells that were injected into mice (not shown). IEC-6/Cdx1 induced tumors were neither encapsulated nor vascularized and were not in®ltrating the neighboring tissues suggesting that these cells did not form invasive tumors (Figure 2c ). This could be due to the lack of appropriate extracellular environment in the subcutaneous compartment. We therefore tested whether injection of IEC-6/Cdx1 cells with adjuvant containing 50% of matrigel would aect the growth and local in®ltration of Cdx1-induced tumors. Injection of IEC-6/Cdx1 cells with matrigel gave rise to a more rapid growth of tumors that were signi®cantly larger than tumors induced by injection of IEC-6/Cdx1 cells alone (Figure 2b ,c). Tumors were more vascularized (Figure 2c ), but still did not show macroscopic signs of local tissue invasion. Histopathological studies of IEC-6/Cdx1-induced tumors revealed a typical phenotype for adenocarcinoma composed of large, irregular glands and papillary structures, covered with intestinal like epithelium containing sparse goblet cells (positive stain with PAS and Alcian blue) (Figure 3 ). Similar histological ®ndings were observed in IEC-6/Cdx1-induced tumors in the presence of matrigel. The most striking dierence in tumors grown with matrigel was the mitotic rate, assessed by counting mitotic ®gures on 10 consecutive view ®elds. The mitotic rate of IEC-6/ Cdx1 tumor was 59 mitotic ®gures per 10 view ®elds with matrigel, while it was only 42 without matrigel. These ®ndings indicate that matrigel addition is very important for the implantation of cells and provides strong mitogenic support for the rapid growth of these cells. However, addition of matrigel did not have a major eect on cellular morphology or dierentiation in growing tumors (not shown).
Tumor formation in the intestine generally involves multiple steps including constitutive activation of proto-oncogenes and attenuation of tumor suppressor genes (Fearon and Vogelstein, 1990) . Ras protooncogenes were frequently found mutated in intestinal tumors (Barbacid, 1990) and constitutive activation of Ras increases the expression level of Cdx1 in colon cancers (Lorentz et al., 1999a) . In order to test whether Ras is involved in transformation of IEC-6/Cdx1 cells we ®rst analysed Ras activity in these cells. We found that Ras proteins were approximately 2.6-fold more bound to GTP in IEC-6/Cdx1 cells than in the parental IEC-6 cells under the same growing conditions ( Figure  4a ,b), while the expression level of Ras was identical in both cells (Figure 4a ). Using isoform speci®c antibodies we found that all Ras types (N-Ras, H-Ras or K-Ras) were activated in IEC-6/Cdx1 cells as compared to control cells (Figure 4a ). These data indicate that activation of dierent Ras isoforms may regulate numerous downstream eectors, including the family of Rho GTPases and PI3 kinase, leading to transformation of IEC-6/Cdx1 cells (Downward, 1998; Khosravi-Far et al., 1995; Qiu et al., 1995) . We therefore analysed activity of each member of the Rho family of GTPases and found that Cdc-42 is activated to a higher level in IEC-6/Cdx1 when compared to IEC-6 cells, while Rho-A activity was decreased in IEC-6/ Cdx1 cells (Figure 4c ). On the contrary, Rac was activated to a similar degree in both transformed and control cells (Figure 4c ). Given the fact that IEC-6/ Cdx1 cells were more resistant to apoptosis than IEC-6 cells (Soubeyran et al., 1999) and since PI3 kinases were shown to mediate anti-apoptotic signals downstream of Ras (Downward, 1998) , we further tested the Figure 3 Histopathological studies of IEC-6/Cdx1-induced tumors. Tumors were taken after 12 weeks of growth and histological sections were stained with standard HES (Hematoxylin/Eosin/Safran), alcian blue that recognizes mucopolysaccharid or PAS (periodic acid Schi) to identify glycoprotein/mucin. Tumors were composed of large, irregular glands and papillary structures, covered with columnar like epithelium containing sparse goblet cells. The left panel shows a section taken at 6100 magni®cation, while the right panel was taken at 6400 magni®cation Cdx1 induces transformation of intestinal epithelial cells P Soubeyran et al activity of PI3 kinase in these cells. Lysates of IEC-6 and IEC-6/Cdx1 cells were subjected to immunoprecipitation with anti-phosphotyrosine antibodies (4G10) and an in vitro PI3 kinase assay. PI3 kinase activity was approximately 3.7 times higher in unstimulated IEC-6/Cdx1 cells than in IEC-6 cells ( Figure 4d ). In addition, we observed a comparable increase in PI3 kinase activity upon EGF stimulation in IEC-6 and IEC-6/Cdx1 cells, suggesting that the ability of growth factors to induce PI3 kinase activity was similar in both cell lines (Figure 4d ). The modulation of Ras, Rho and PI3 kinase in IEC-6/Cdx1 indicated possible involvement of these pathways in Cdx1-induced cell transformation. In order to test this hypothesis, we studied the eect of inhibitors of Ras/Rho and PI3 kinase, individually or in combinations, on the ability of IEC-6/Cdx1 cells to grow in soft agar. Treatment of IEC-6/Cdx1 cells with the geranylgeranyl transferase inhibitor , that inhibits the family of small Rho GTPases and several isoforms of Ras (Sebti and Hamilton, 1997; Prendergast, 2000) , or the PI3 kinase inhibitor LY294002 led to approximately 50% reduction in colony formation as compared to mock-treated cells ( Figure 5 ). Addition of the farnesyl transferase inhibitor (FTI-277), known to block H-Ras and NRas, but not K-Ras (Sebti and Hamilton, 1997), weakly inhibited growth of IEC/Cdx1 cells in soft agar (Figure 5a,b) . A combination of GGTI-286 and LY294002 inhibitors led to a complete inhibition of colony formation, while a combination of FTI-277 and LY294002 partially blocked in vitro transformation of IEC-6/Cdx1 cells (Figure 5a,b) . The same concentrations of inhibitors were also able to eciently block cell proliferation of IEC-6/Cdx1 cells (data not shown). Taken together our data indicate that Ras/Rho and PI3 kinase play important roles in mediating the oncogenic potential of Cdx1 and that their combined inhibition is required to block anchorage-independent growth and cell transformation of IEC-6/Cdx1 cells.
Discussion
The Caudal-like homeobox gene Cdx1 has been implicated in the regulation of proliferation and (Bijl et al., 1997; Mallo et al., 1998; Soubeyran et al., 1999) . Moreover, several reports indicated a broader role for Cdx1 in the tumor pathogenesis across the intestine, including stomach, esophagus and liver (Silberg et al., 1997; Ren et al., 2000) . In this study we show that Cdx1 acts as a proto-oncogene in its native environment i.e. intestinal epithelial cells. Expression of Cdx1 in nontransformed intestinal epithelial (IEC-6) cells induces anchorage-independent growth in soft agar and tumor formation in nude mice, the hallmarks of neoplastic cells. Histological analysis revealed features common for adenocarcinoma phenotype without signs of local in®ltration into neighboring tissues (Figure 2 ). Tumorigenicity of these cells was rather weak displaying slow growing tumors that were dependent on the appropriate extracellular support for their growth. IEC-6/ Cdx1 cells form signi®cantly larger tumors in the presence of matrigel, a source of mitogens and extracellular matrix components (Figure 2) . The critical eect of addition of matrigel to injected cells was the increased proliferation of IEC-6/Cdx1 cells as evidenced by faster tumor growth and increased mitotic rate (Figures 2 and 3 ). This suggests that deregulation of Cdx1 expression in intestinal epithelia may be responsible for uncontrolled proliferation and initiation of tumor development. This is consistent with a recent report showing that induction of Cdx1 expression was correlated with the initial phase of cholangiocarcinoma, while Cdx1 expression was down-regulated during the later stages of cancer progression (Ren et al., 2000) . On the other hand, high expression of murine Cdx1 in cultured ®broblasts or IEC-6 cells may also lead to cell cycle arrest and inhibition of growth (Lynch et al., 2000) . The authors used the adenovirus system to obtain very high protein expression levels in these cells suggesting that Cdx1 may mediate opposing cell responses: transformation (this study and Maulbecker and Gruss, 1993) versus cell cycle arrest (Lynch et al., 2000) , depending on its expression level. The classical process of isolation of a pool of resistant cells expressing Cdx1, applied in this and Maulbecker and Gruss studies, takes several weeks and favors cells expressing the amount of Cdx1 that gives them a competitive advantage in proliferation over slower growing cells. This process resembles tumor development where only certain cell clones are selected for The most striking eect during Cdx1-induced transformation of IEC-6 cells is the increase in cell proliferation. This could be induced by the direct Cdx1 regulation of immediate early genes or indirectly via transactivation of proteins involved in mitogenic signaling networks (Chariot et al., 1999; Lorentz et al., 1999b) . Cdx1 was shown to directly transactivate Hoxa-7 by binding to a conserved TTTATG motif that is also identi®ed in the regulatory regions of more than a dozen of other homeobox genes (Subramanian et al., 1995) . We have previously shown that Cdx1 strongly activates a reporter gene containing the Hoxa-7 promoter when transfected in IEC-6/Cdx1 cells (Soubeyran et al., 1999) . Importantly Cdx1 and several other Hox genes, including Hoxa-7, are also able to induce cell transformation in cultured ®broblasts and tumor growth in nude mice (Maulbecker and Gruss, 1993) . In addition, here we report identi®cation of Ras, Rho and PI3 kinase as Cdx1 target pathways required for transformation of IEC-6 cells. Ras was previously shown to up-regulate the expression of Cdx1 in colorectal cancers (Lorentz et al., 1999a) , indicating a possible positive feed back loop whereby expression of Cdx1 may lead to the activation of Ras while activated Ras could in turn further increase the level of Cdx1. Since no genetic alterations of Ras genes have been detected in IEC-6/ Cdx1 cells (data not shown) it appears that constitutive activation of normal Ras isoforms may be critical for Cdx1-induced transformation of IEC-6 cells. This is consistent with the results showing that overexpression of the normal H-Ras proto-oncogene can lead to transformation of NIH3T3 cells in culture (Pulciani et al., 1985) . Therefore, activation of known Ras eectors, Rho and PI3 kinase, rather than regulation of their expression, is aected in IEC-6/ Cdx1 cells (Figure 4) . Moreover, constitutive active forms of RhoA and Rac1 can also cause uncontrolled proliferation and tumor growth (Khosravi-Far et al., 1995; Qiu et al., 1995) . Increased migration and morphological changes in IEC-6/Cdx1 cells (Soubeyran et al., 1999) may well be explained by changes in activity of Rho GTPases: a decrease in Rho-A, an increase in Cdc42 and constitutive high Rac activities. On the other hand, activation of PI3 kinase, which is linked to survival pathways, is increased in IEC-6/ Cdx1 cells thus potentially mediating their resistance to apoptosis. In addition, we have detected a general increase in tyrosine phosphorylation in IEC-6/Cdx1 cells as compared to parental IEC-6 cells (data not shown) and PI3 kinase activity was coupled preferentially to tyrosine phosphorylated proteins in IEC-6/ Cdx1 cells (Figure 4d ). This is consistent with our observation that Cdx1 renders the IEC-6 cells more responsive to factors secreted by both parental or Cdx1 expressing IEC-6 cells (Soubeyran et al., 1999) . At present, very little is known about the molecular mechanisms by which Cdx1 may activate speci®c protein tyrosine kinases.
The strong eect of matrigel on IEC-6/Cdx1 tumor growth indicates that mitogenic stimuli cooperate with Cdx1 leading to a more profound transformation (Figure 2 ). Similar observations were found for the IL-3-dependent Hoxb-8/Hox2.4-induced transformation (Perkins and Cory, 1993) . The other important conclusion from this study is that combined inhibition of mitogenic and survival pathways is necessary to block anchorage-independent growth of IEC-6/Cdx1 cells. We used FTI and GGTI that were shown to block tumor growth induced by oncogenic Ras proteins (Sebti and Hamilton, 1997; Prendergast, 2000) and LY294002 synthetic PI3 kinase inhibitors, individually or in combination, to block colony formation of IEC-6/Cdx1 cells in vitro. Although both FTI and GGTI block prenylation of Ras GTPases, the precise mechanism by which they inhibit tumor growth is not known (Sebti and Hamilton, 1997; Prendergast, 2000) . There appear to be several dierences in their actions. GGTIs block Rho GTPases and several Ras isoforms, induce apoptosis in adherent cells and block the cell cycle in G1 phase (Sebti and Hamilton, 1997; Adnane et al., 1998; Prendergast, 2000) . On the other hand, FTIs preferentially inhibit H-Ras and N-Ras, but not K-Ras or Rho GTPases, mediate either a G1 block or a G2/M enrichment and induce apoptosis only in non-adherent cells (Sebti and Hamilton, 1997; Prendergast, 2000) . This is consistent with the strong inhibition of colony formation observed in IEC-6/Cdx1 cells by geranylgeranyl transferase inhibitors but not by the treatment with farnesyl transferase inhibitors ( Figure 5 ). In addition, inhibition of PI3 kinase pathways strongly reduces growth of IEC-6/Cdx1 cells in semi-solid medium ( Figure 5 ), and combined treatment with both Ras/Rho inhibitors (GGTI) and PI3 kinase inhibitors completely block transformation of IEC-6/Cdx1 cells in vitro ( Figure 5 ). Taken together, our data suggest that expression of Cdx1 must be tightly regulated in vivo since deregulation of its functions in intestinal epithelial cells may lead to unrestrained cell proliferation and subsequent cancer development. Moreover, they also indicate that the design of an ecient anti-cancer treatment of Cdx1-expressing tumors will require a combined inhibition of Ras/Rho and PI3-kinase signaling pathways in tumor cells.
Materials and methods

Cell culture
The rat intestinal cell line IEC-6 was obtained from the American Type Culture Collection (ATCC). IEC-6/Cdx1 cells were generated as described previously (Soubeyran et al., 1999) . Except for experiments, they were maintained in the same standard culture medium as the IEC-6 cells supplemented with G418 (400 mg/ml). When cells reached conuence, they were dissociated with 0.05% Trypsin and 0.02% EDTA in Puck's saline A and replated on 100-mm Petri dishes. The two cell lines were grown in culture for less than 15 passages.
Soft agar assays
IEC-6/Cdx1 cell were plated at concentrations of 25610 3 , 50610 3 and 100610 3 cells in 0.4 ml DMEM supplemented with 5% FBS and 0.3% low-melting-temperature agarose (Sigma) in 12-well plates coated with a 0.4 ml layer of DMEM supplemented with 5% FBS and 0.6% low-meltingtemperature agarose. Dishes were kept at 378C and 5% CO 2 and monitored after 1 and 2 weeks for colony formation. Cells were photographed after 2 weeks and colonies were counted by scoring the number of colonies in ®ve randomly chosen view ®elds using a 406 objective. As a negative control we used IEC-6 parental cells in the same conditions. v-Src and v-Met transformed ®broblasts (50610 3 ) were used as positive controls. To study the eect of inhibitors on the growth of colonies in soft agar, the same assays were conducted. Cells (50610 3 ) were either mock treated or treated with 5 mM of the geranylgeranyl transferase inhibitor GGTI-286 (Calbiochem), 300 nM of the farnesyl transferase inhibitor FTI-277 (Calbiochem) or 5 mM of the PI3 kinase inhibitor LY294002 (Sigma) or their combinations as indicated.
Animal studies
Animal work was approved by the local board of animal experimentation and thus performed according to the UKCCCR guidelines (Workman, 1988) . Tumorigenicity was assayed by subcutaneous injection of 3610 6 IEC-6 or IEC-6/Cdx1 cells, resuspended in 200 ml of phosphate buered saline, into the¯anks of 4 ± 6 week-old athymic (Balb/c nu/nu) male mice obtained from M&B, Denmark. As a positive control 1610 6 v-Src/NIH3T3 or 1610 6 v-met/ FR3, were injected. Animals were monitored weekly for tumor growth by measuring tumor size in two dimensions with linear calipers and the tumor volume was calculated by the formula p/66 width 2 6 length. Animals that showed no tumor appearance after 12 weeks were considered as negative for tumor growth. For injection of cells together with matrigel, 3610 6 IEC-6 or IEC-6/Cdx1 cells were resuspended in 100 ml of cold phosphate buered saline mixed with 100 ml of matrigel (Becton Dickinson) and injected subcutaneously as previously described. Animals were sacri®ced at 4, 8 and 12 weeks post-injection and tumors were removed, ®xed in 70% ethanol in PBS and embedded in paran. Four 1 m thick sections were obtained and stained with Hematoxylin/Eosin/Safran for standard examination, and with Alcian blue or PAS to detect glycoproteins and mucin production. Mitotic rates were assessed by counting mitotic ®gures on 10 consecutive high power ®elds (HPF=X400).
Ras and Rho pull-down assays
The activation status of Ras was assayed using a GSTfusion protein of the Ras binding domain (RBD) of Raf-1 (1 ± 149) which has a high anity to GTP-loaded, active Ras as previously described (Blaukat et al., 2000) . Precipitated Ras was analysed by 15% SDS ± PAGE followed by Western blotting using 1 mg/ml of a monoclonal pan-Ras antibody (R02120, Transduction Laboratories), 2 mg/ml of a monoclonal antibody speci®c for H-Ras (F235), K-Ras (F234) or N-Ras (F155) purchased from Santa Cruz. To measure Rho A, Rac1, and cdc42 activation status, cells were lysed in lysis buer (50 mM Tris-HCl pH 7.5, 1% Triton X-100, 0.5% Sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 ng/ml MgCl 2 , 10 mg/ml aprotinin and leupeptin, 1 mM PMSF, 1 mM Sodium Orthovanadate). The crude lysates were cleared by a 5 min centrifugation and incubated with 20 mg of GST-Rhotekin, GST-Crib PAK, or GST-Crib WASP bound to sepharose beads (provided by Pontus Aspenstrom and Sophia Edlund) for 10 min at 48C. The beads were then washed three times with washing buer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 150 mM NaCl, 10 mM MgCl 2 , 10 mg/ml aprotinin and leupeptin, 1 mM PMSF). Precipitated proteins were resolved on a 12% SDS ± PAGE followed by Western blotting with monoclonal antibodies speci®c for Rho A (sc-418, Santa Cruz), Rac1 (05389 Upstate Biotechnology) or cdc42 (C70820, Transduction Laboratories).
Phosphatidyl inositol 3 kinase assay IEC-6 or IEC-6/Cdx1 cells were starved in serum-free medium for 24 h and either mock-treated or stimulated with 100 ng/ml of epidermal growth factor (Intergen) in serum-free DMEM for 10 min at 378C. Cells were subsequently washed twice with ice-cold PBS containing 100 mM Na 3 VO 4 and lysed in 1 ml Lysis buer (25 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% NP-40, 100 mM Na 3 VO 4 , 1% Aprotinin and 1 mM PMSF). Equal amounts of protein lysates (300 mg in 500 ml) were subjected to immunoprecipitation (IP) using anti-phosphotyrosine antibodies (4G10). The precipitates were washed twice with PBS/1% NP-40, followed by PBS, 0.1 M Tris/HCl pH 7.5/ 0.5 M LiCl and ®nally 25 mM HEPES pH 7.5/100 mM NaCl/1 mM EDTA. The precipitates were then resuspended in 50 ml of presonicated phosphatidylinositol substrate (0.2 m in 25 mM HEPES pH 7.5, 100 mM NaCl, and 1 mM EGTA) and incubated 10 min at room temperature. Each sample was labeled with 10 mCi g 32 P-ATP for 10 min at room temperature. Reactions were stopped by adding 100 ml of chloroform-methanol-HCl (50 : 100 : 1) and the complete liquid was transferred to a new tube. Lipids were extracted with 200 ml chloroform, and after mixing and centrifugation the lower`organic' phase was transferred to a new tube. The organic phase was washed once with 100 ml methanol-1 M HCl (1 : 1) and the upper phase was discarded. The rest was concentrated by vacuum centrifugation. Finally the lipid fraction was resuspended in 20 ml of chloroform and applied to a DC-plate preimpregnated with 1% potassium oxalate. Phospholipids were resolved by thin layer chromatography in freshly prepared chloroformmethanol-ammonia-water (43 : 38 : 5 : 7) for 45 min in a closed Glass chamber at room temperature. Plates were air-dried and radioactive phospholids were visualized using a Fuji phosphoimager BAS2000.
